Praxis Precision Medicines Inc (PRAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -92,561 | -303,268 | -214,357 | -140,423 | -69,296 |
| Depreciation Amortization | -616 | -3,452 | -2,809 | -2,123 | -1,182 |
| Accounts payable and accrued liabilities | 6,530 | 12,097 | 18,291 | 16,304 | 10,381 |
| Other Working Capital | -10,284 | 22,678 | 19,664 | 17,801 | 8,435 |
| Other Operating Activity | 10,779 | 22,877 | 6,468 | 755 | -1,348 |
| Operating Cash Flow | $-86,152 | $-249,068 | $-172,743 | $-107,686 | $-53,010 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -62 | -56 | -56 | -56 | N/A |
| Purchase Of Investment | -344,213 | -311,092 | 17,299 | -33,114 | -51,064 |
| Investing Cash Flow | $-344,275 | $-311,148 | $17,243 | $-33,170 | $-51,064 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 622,354 | 704,262 | 90,925 | 84,117 | 55,464 |
| Other Financing Activity | -12,923 | -2,089 | -1,270 | -1,218 | -1,195 |
| Financing Cash Flow | $609,431 | $702,173 | $89,655 | $82,899 | $54,269 |
| Beginning Cash Position | 357,745 | 215,788 | 215,788 | 215,788 | 215,788 |
| End Cash Position | 536,749 | 357,745 | 149,943 | 157,831 | 165,983 |
| Net Cash Flow | $179,004 | $141,957 | $-65,845 | $-57,957 | $-49,805 |
| Free Cash Flow | |||||
| Operating Cash Flow | -86,152 | -249,068 | -172,743 | -107,686 | -53,010 |
| Capital Expenditure | -62 | -56 | -56 | -56 | 0 |
| Free Cash Flow | -86,214 | -249,124 | -172,799 | -107,742 | -53,010 |